CrushSCI.com
142.7Average days
105Median days
28Fastest days
630Longest days
7932025 publications

Paper Review Records

All Paper Review Records

25 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

68 days

Collapsing focal segmental glomerulosclerosis progression to kidney failure following combination therapy with pembrolizumab and enfortumab vedotin: a case report

Authors
George Hitti; Caroline Gee; Johnathan Zuckerman; Ramy HannaShow moreShow less
Affiliations
1. School of Medicine, University of California, Irvine, Irvine, USA; 2. Department of Pathology, University of California, Los Angeles, Los Angeles, USA; 3. Department of Nephrology, University of California, Irvine, Orange, USAShow moreShow less
Source PDF DOI Publisher page
162 days

Real-world observational changes in biomarkers and safety profile of finerenone in patients with non-diabetic chronic kidney disease: a systematic review and meta-analysis

Authors
Zhe Zhang; Xiaoyi Liu; Peiyi Ye; Yaozhong Kong; Chao XieShow moreShow less
Affiliations
1. The First People’s Hospital of Foshan (Foshan Hospital Affiliated to Southern University of Science and Technology), School of Medicine, Southern University of Science and Technology, Guangdong, ChinaShow moreShow less
Source PDF DOI Publisher page
54 days

CAIGAN study protocol: complement activation in primary IgA nephropathy—study protocol for an international prospective multicenter observational cohort study

Authors
Gabriella Guzzo; Manuel Pascual; Francisco M. Herrera-Gomez; Valentin Rousson; Laureane Mittaz-Crettol; Carole Gengler; Hassib Chehade; Andreas D. Kistler; Roberta Fenoglio; Dario Roccatello; Uyen Huynh-Do; Fadi Fakhouri; Daniel TetaShow moreShow less
Affiliations
1. Service of Nephrology, Valais Hospital, Sion, Switzerland; 2. Service of Nephrology and Hypertension, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland; 3. Transplantation Center, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; 4. Department of Nephrology, Burgos University Hospital, Burgos, Spain; 5. Center for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland; 6. Genetic Medicine, Department of Laboratory Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; 7. Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; 8. Division of Pediatric Nephrology, Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; 9. Department of Medicine, Spital Thurgau AG, Frauenfeld, Switzerland and Faculty of Medicine, University of Zurich, Zurich, Switzerland; 10. University Center of Excellence on Nephrological, Rheumatological and Rare Diseases including Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases, Coordinating Center of the Inter-regional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), San Giovanni Bosco Hub Hospital, ASL Città di Torino, Department of Clinical and Biological Sciences of the University of Turin, Turin, Italy; 11. Division of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandShow moreShow less
Source PDF DOI Publisher page
86 days

Sequential multisystem adverse effects associated with mycophenolate mofetil in a kidney transplant recipient:a case report

Authors
Reyhane Motamedifar; Masoumeh Sohrabi; Mahsa PanahishokouhShow moreShow less
Affiliations
1. Department of Nephrology, Isfahan Kidney Disease Research Center, Korshid Hospital, Isfahan University of Medical Sciences, Isfahan, Iran; 2. Department of Clinical Pharmacy and Services, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran; 3. Department of Clinical Pharmacy and Pharmacy Practice and Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, IranShow moreShow less
Source PDF DOI Publisher page
105 days

Early renal adaptation after living kidney donation assessed by multiparametric MRI

Authors
Eva Carlsson; Per Liss; Jan Weis; Amir Sedigh; Maria K. SvenssonShow moreShow less
Affiliations
1. Department of Medical Sciences, Renal Medicine, Uppsala University Hospital, Uppsala SE-413 45, Sweden; 2. Department of Surgical Sciences; Radiology, Uppsala University, Uppsala, Sweden; 3. Department of Medical Physics, Uppsala University Hospital, Uppsala, Sweden; 4. Department of Surgical Sciences, Transplantation Surgery, Uppsala University, Uppsala, Sweden; 5. Uppsala Clinical Research Center, Uppsala, SwedenShow moreShow less
Source PDF DOI Publisher page
85 days

Illness experiences, psychosocial problems, and coping processes among individuals with autosomal dominant polycystic kidney disease: a qualitative study

Authors
Mesudiye Bulut; Yunus Kaya; Buse Hacıoğlu; Hadim AkoğluShow moreShow less
Affiliations
1. Department of Nephrology, University of Health Sciences, Gülhane Training and Research Hospital, Etlik, Türkiye; 2. Department of Nursing, Faculty of Health Sciences, Aksaray University, Aksaray, TürkiyeShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does BMC Nephrology take to review a manuscript?

As of 2026-11-19, CrushSCI has 25 complete review records for BMC Nephrology. The fastest paper went from submission to acceptance in 28 days (Efficacy and safety of BAFF/APRIL-pathway inhibitors versus placebo in adults with IgA nephropathy: a systematic review with pairwise and network meta-analysis, received 2026-07-08, accepted 2026-08-05); the slowest took 630 days. The average is 142.7 days and the median is 105 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.